Literature DB >> 23580562

Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome.

Theodoros Kelesidis, Ryan Tewhey, Romney M Humphries.   

Abstract

Entities:  

Keywords:  cardiolipin synthetase; hypercalcaemia; whole-genome sequencing

Mesh：

Substances：

Year:  2013        PMID： 23580562      PMCID： PMC6373497          DOI： 10.1093/jac/dkt117

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.758


× No keyword cloud information.
  9 in total

1.  Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.

Authors:  P C Fuchs; A L Barry; S D Brown
Journal:  Diagn Microbiol Infect Dis       Date:  2000-09       Impact factor: 2.803

2.  Genetic basis for daptomycin resistance in enterococci.

Authors:  Kelli L Palmer; Anu Daniel; Crystal Hardy; Jared Silverman; Michael S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

3.  Genetic basis for in vivo daptomycin resistance in enterococci.

Authors:  Cesar A Arias; Diana Panesso; Danielle M McGrath; Xiang Qin; Maria F Mojica; Corwin Miller; Lorena Diaz; Truc T Tran; Sandra Rincon; E Magda Barbu; Jinnethe Reyes; Jung H Roh; Elizabeth Lobos; Erica Sodergren; Renata Pasqualini; Wadih Arap; John P Quinn; Yousif Shamoo; Barbara E Murray; George M Weinstock
Journal:  N Engl J Med       Date:  2011-09-08       Impact factor: 91.245

4.  Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.

Authors:  H Hanberger; L E Nilsson; R Maller; B Isaksson
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis.

Authors:  Noha N Salama; Jonathan H Segal; Mariann D Churchwell; Jignesh H Patel; Lihong Gao; Michael Heung; Bruce A Mueller
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

6.  De novo daptomycin-nonsusceptible enterococcal infections.

Authors:  Theodoros Kelesidis; Romney Humphries; Daniel Z Uslan; David Pegues
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 16.126

7.  Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.

Authors:  Theodoros Kelesidis; Romney Humphries; Daniel Z Uslan; David A Pegues
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 20.999

8.  Case-control study comparing de novo and daptomycin-exposed daptomycin-nonsusceptible Enterococcus infections.

Authors:  Theodoros Kelesidis; Angela L P Chow; Romney Humphries; Daniel Z Uslan; David Pegues
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.938

9.  Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium.

Authors:  Romney M Humphries; Theodoros Kelesidis; Ryan Tewhey; Warren E Rose; Nicholas Schork; Victor Nizet; George Sakoulas
Journal:  Antimicrob Agents Chemother       Date:  2012-09-04       Impact factor: 5.938
  9 in total
  16 in total

Review 1.  Mechanisms of drug resistance: daptomycin resistance.

Authors:  Truc T Tran; Jose M Munita; Cesar A Arias
Journal:  Ann N Y Acad Sci       Date:  2015-10-23       Impact factor: 5.691

2.  Variability of Daptomycin MIC Values for Enterococcus faecium When Measured by Reference Broth Microdilution and Gradient Diffusion Tests.

Authors:  Shelley A Campeau; Audrey N Schuetz; Peggy Kohner; Cesar A Arias; Peera Hemarajata; Jennifer Dien Bard; Romney M Humphries
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

3.  Mutations associated with reduced surotomycin susceptibility in Clostridium difficile and Enterococcus species.

Authors:  Hannah M Adams; Xiang Li; Carmela Mascio; Laurent Chesnel; Kelli L Palmer
Journal:  Antimicrob Agents Chemother       Date:  2015-05-04       Impact factor: 5.191

4.  Characterization of daptomycin non-susceptible Enterococcus faecium producing urinary tract infection in a renal transplant recipient.

Authors:  Antonio Sorlózano; Diana Panesso; José María Navarro-Marí; Cesar A Arias; José Gutiérrez-Fernández
Journal:  Rev Esp Quimioter       Date:  2015-08       Impact factor: 1.553

Review 5.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 6.  [Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].

Authors:  Sandra Rincón; Diana Panesso; Lorena Díaz; Lina P Carvajal; Jinnethe Reyes; José M Munita; César A Arias
Journal:  Biomedica       Date:  2014-04       Impact factor: 0.935

7.  Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp.

Authors:  April M Bobenchik; Janet A Hindler; Carmen L Giltner; Sandra Saeki; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

8.  Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons.

Authors:  Nagendra N Mishra; Arnold S Bayer; Christopher Weidenmaier; Timo Grau; Stefanie Wanner; Stefania Stefani; Viviana Cafiso; Taschia Bertuccio; Michael R Yeaman; Cynthia C Nast; Soo-Jin Yang
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

Review 9.  Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?

Authors:  Ana M Guzman Prieto; Willem van Schaik; Malbert R C Rogers; Teresa M Coque; Fernando Baquero; Jukka Corander; Rob J L Willems
Journal:  Front Microbiol       Date:  2016-05-26       Impact factor: 5.640

10.  Emergence of a daptomycin-non-susceptible Enterococcus faecium strain that encodes mutations in DNA repair genes after high-dose daptomycin therapy.

Authors:  Takashi Matono; Kayoko Hayakawa; Risen Hirai; Akira Tanimura; Kei Yamamoto; Yoshihiro Fujiya; Momoko Mawatari; Satoshi Kutsuna; Nozomi Takeshita; Kazuhisa Mezaki; Norio Ohmagari; Tohru Miyoshi-Akiyama
Journal:  BMC Res Notes       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.